[Form 4] Franklin Covey Company Insider Trading Activity

Rhea-AI Filing Summary

Franklin Covey Co. (NYSE: FC) – Form 4 insider filing

President of the Enterprise Division, Jennifer C. Colosimo, reported the acquisition of 1,831 common shares on 11 Jul 2025. The transaction was coded “A,” indicating an award or grant, and was executed at $0.00 per share in connection with the company’s FY25 Long-Term Incentive Plan, which vests in three tranches (Oct 2025, Oct 2026, Oct 2027). Following the grant, Colosimo’s direct holding increases to 37,336 shares. No derivative securities or open-market purchases were disclosed.

The filing represents a routine equity incentive grant rather than a market purchase, so cash was not exchanged and dilution is negligible relative to Franklin Covey’s total shares outstanding.

Insights

Securities Analyst

TL;DR: Small incentive-plan share grant; routine, non-cash, immaterial to valuation.

This Form 4 shows an equity incentive vesting for 1,831 shares granted to a senior officer. At roughly 0.01% of the company’s outstanding shares, the award neither signals insider buying conviction nor materially alters insider ownership concentration. It simply reflects scheduled LTIP vesting and ongoing alignment of management compensation with shareholder value. From a capital-markets standpoint, the event is not impactful to earnings, cash flow, or share count.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Colosimo Jennifer C.

(Last) (First) (Middle)

2200 WEST PARKWAY BLVD.

(Street)

SALT LAKE CITY UT 84119

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FRANKLIN COVEY CO [ FC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Enterprise Division

3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	07/11/2025		A		1,831(1)	A	$0	37,336	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. FY25 LTIP, third vesting Oct 2025, Oct 2026, Oct 2027.

	Stephanie King, Attorney-in-Fact	07/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did FC file on 14 Jul 2025?

Jennifer C. Colosimo reported receiving 1,831 FC common shares on 11 Jul 2025 under the FY25 LTIP, at $0 cost.

Was the FC share acquisition an open-market purchase?

No. The Form 4 lists transaction code “A,” indicating an equity award/grant, not a market purchase.

How many Franklin Covey shares does Colosimo now own?

After the grant, her direct ownership totals 37,336 shares.

Does the grant affect FC’s share count materially?

The 1,831-share award is immaterial relative to total outstanding shares and has negligible dilution impact.